Dhampur Bio Organics Publishes EGM Notice for ₹305 Cr Business Transfer

3 min read     Updated on 25 Apr 2026, 02:14 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics has published its EGM notice in Business Standard confirming the May 18, 2026 meeting for shareholder approval of the ₹305 crore Meerganj unit transfer and key leadership transitions. The notice provides comprehensive e-voting procedures and confirms electronic dispatch completion on April 24, 2026.

powered bylight_fuzz_icon
38371201

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics Limited has published its Extraordinary General Meeting notice in Business Standard on April 25, 2026, confirming the EGM scheduled for Monday, May 18, 2026, at 4:00 PM IST through video conferencing. The meeting seeks shareholder approval for strategic business decisions including a major business transfer worth ₹305.00 crores and key leadership changes.

Business Transfer Proposal

The board proposes to transfer the Meerganj sugar manufacturing unit located at Bareilly, Uttar Pradesh, to Forever Global Enterprises Limited on a slump sale basis for a lump sum consideration of ₹305.00 crores. The transfer includes all assets and liabilities of the unit as a going concern, based on an independent valuer's report. The Meerganj unit contributes 15.52% to the company's total turnover, representing ₹423.24 crores out of ₹2,714.40 crores as per audited financial statements for March 31, 2025.

Parameter: Details
Consideration Amount: ₹305.00 crores
Unit Location: Meerganj, Bareilly, Uttar Pradesh
Buyer: Forever Global Enterprises Limited
Transaction Type: Slump sale basis
Turnover Contribution: 15.52% (₹423.24 crores)

The board believes the transfer will enable the company to focus on high-margin value-added businesses, become cash surplus and net debt free, and improve overall financial efficiency. The sale proceeds will primarily be used to repay and optimise company debts and maintain financial corpus for future growth opportunities.

Leadership Changes

Mr. Sandeep Kumar, currently Whole-time Director, will transition to Non-Executive Non-Independent Director effective May 5, 2026, upon completion of his tenure. He brings over 45 years of experience in operations, projects, and administration.

Mr. Nalin Kumar Gupta, currently Chief Financial Officer, has been appointed as Additional and Whole-time Director for a three-year term from May 5, 2026, to May 4, 2029. A Chartered Accountant with around 30 years of experience, he has been associated with the company for more than 25 years.

Proposed Remuneration Package

The board has proposed the following annual remuneration for Mr. Nalin Kumar Gupta as Whole-time Director:

Component: Amount (per annum)
Basic Salary: ₹44,55,240
House Rent Allowance: ₹22,27,620
Other Allowances: ₹18,30,732
Conveyance: Company maintained vehicle with driver

Additional benefits include leave encashment, leave travel allowance, performance-linked variable pay, ESOP, provident fund, and gratuity as per company policy and applicable laws. The remuneration package includes provisions for annual increases of up to 10%.

EGM and Voting Details

The company has completed electronic dispatch of the EGM notice to shareholders on Friday, April 24, 2026. The remote e-voting period commences on Thursday, May 14, 2026, at 9:00 AM and concludes on Sunday, May 17, 2026, at 5:00 PM. Shareholders whose names appear in the Register of Members as of the cut-off date of May 11, 2026, are eligible to vote.

EGM Parameter: Details
Meeting Date: Monday, May 18, 2026 at 4:00 PM
Mode: Video Conferencing/OAVM
Notice Dispatch: April 24, 2026
E-voting Period: May 14-17, 2026
Cut-off Date: May 11, 2026
Scrutinizer: Mr. Saket Sharma, GSK & Associates

The EGM will be conducted through VC/OAVM without physical attendance, in compliance with MCA and SEBI circulars. The business transfer requires approval through a special resolution under Section 180(1)(a) of the Companies Act, 2013, and Regulation 37A of the SEBI Listing Regulations. The leadership appointments require ordinary and special resolutions as applicable. The scrutinizer for the EGM is Mr. Saket Sharma, Partner, M/s GSK & Associates.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+1.75%-8.26%-5.06%+54.14%+61.46%-32.19%

How will the divestiture of the Meerganj unit impact Dhampur Bio Organics' sugar production capacity and market position in the competitive sugar industry?

What specific high-margin value-added businesses does Dhampur Bio Organics plan to focus on with the proceeds from this asset sale?

Could this transaction signal a broader consolidation trend in India's sugar manufacturing sector, and might other players follow similar divestiture strategies?

Dhampur Bio Organics Submits Q4FY26 SEBI Depositories Certificate Confirming No Physical Share Holdings

1 min read     Updated on 07 Apr 2026, 02:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics Limited filed its Q4FY26 certificate under SEBI Regulation 74(5) on April 07, 2026, for the quarter ended March 31, 2026. The certificate, confirmed by registrar Alankit Assignments Limited, states that no shares are held in physical form, indicating complete dematerialization of the company's share capital. This filing represents standard regulatory compliance with SEBI Depositories and Participants Regulations.

powered bylight_fuzz_icon
37097845

*this image is generated using AI for illustrative purposes only.

Dhampur bio organics Limited has submitted its quarterly compliance certificate under SEBI Depositories and Participants Regulations for the quarter ended March 31, 2026. The certificate was filed with both BSE Limited and National Stock Exchange of India on April 07, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This quarterly filing is a standard regulatory requirement for listed companies to confirm the status of their share holdings.

Filing Details: Information
Filing Date: April 07, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
BSE Scrip Code: 543593
NSE Symbol: DBOL

Share Dematerialization Status

Alankit Assignments Limited, serving as the company's Registrar and Share Transfer Agent, provided confirmation regarding the share holding status. The certificate dated April 01, 2026, contains a crucial confirmation about the company's share structure.

The registrar confirmed that there are no holdings of shares in physical form in the company as of March 31, 2026. This indicates complete dematerialization of the company's share capital, with all shares held in electronic format through depositories.

Key Participants

The filing was signed by Ashu Rawat, Company Secretary and Compliance Officer of Dhampur Bio Organics Limited. The confirmation certificate from the registrar was signed by Kamal Garg, General Manager at Alankit Assignments Limited.

Signatory Details: Role
Ashu Rawat: Company Secretary & Compliance Officer
Kamal Garg: General Manager, Alankit Assignments Limited

This quarterly compliance filing demonstrates the company's adherence to SEBI regulations and confirms the complete electronic holding of its share capital, eliminating any physical share certificates in circulation.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+1.75%-8.26%-5.06%+54.14%+61.46%-32.19%

Will Dhampur Bio Organics' complete share dematerialization improve trading liquidity and attract more institutional investors?

How might the elimination of physical shares impact the company's future corporate actions like stock splits or bonus issues?

Could this full dematerialization status make Dhampur Bio Organics a more attractive target for inclusion in major stock indices?

More News on Dhampur Bio Organics

1 Year Returns:+61.46%